Overview

Natalizumab in Preventing Post-partum Relapses in Multiple Sclerosis

Status:
Recruiting
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
The purpose of this study is to evaluate if monthly natalizumab, initiated after delivery, is effective in preventing postpartum relapses.
Phase:
Phase 4
Details
Lead Sponsor:
State University of New York at Buffalo
Treatments:
Natalizumab